Q32 Bio (FRA:DB0) EPS without NRI: €2.37 (TTM As of Mar. 2026)


FRA:DB0 Q32 Bio Inc FRA:DB0
17 GF Score
Price €11.33
! 6 Warning Signs
View Full Analysis

What is Q32 Bio EPS without NRI?

Q32 Bio FRA:DB0 -0.18% 17 EPS without NRI is €2.37 as of Mar. 2026. GuruFocus rates FRA:DB0 with a GF Score™ of 17/100. The stock has 6 warning signs investors should review. Among 1,166 Biotechnology companies, Q32 Bio ranks worse than 85763.21% on this metric.

Q32 Bio's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €-0.47. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €2.37.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Q32 Bio's EPS without NRI or its related term are showing as below:

During the past 5 years, Q32 Bio's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -35.40% per year. The lowest was -35.40% per year. And the median was -35.40% per year.

FRA:DB0's 3-Year EPS without NRI Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 16.65
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Q32 Bio's EPS (Diluted) for the three months ended in Mar. 2026 was €-0.47. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.37.

Q32 Bio's EPS (Basic) for the three months ended in Mar. 2026 was €-0.47. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.37.


Q32 Bio  (FRA:DB0) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Q32 Bio EPS without NRI Related Terms


Q32 Bio EPS without NRI Historical Data

* Premium members only.

The historical data trend for Q32 Bio's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q32 Bio EPS without NRI Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
-2.79 -3.20 -3.76 -7.47 1.25

Q32 Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.83 -0.68 -0.51 4.02 -0.47

FRA:DB0 vs CAMP, CDXS, KROS: EPS without NRI Comparison

For the Biotechnology subindustry, Q32 Bio's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q32 Bio PE Ratio without NRI vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Q32 Bio's PE Ratio without NRI falls into.


FRA:DB0
17GF Score
Q32 Bio Inc FRA:DB0
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q32 Bio EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €2.37 mean?
Q32 Bio (FRA:DB0) has a EPS without NRI of €2.37 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Q32 Bio and its competitors. According to the industry distribution chart, Q32 Bio ranks #999999 out of 1166 companies in the Biotechnology industry.
Is Q32 Bio's EPS without NRI too high?
Q32 Bio's current EPS without NRI is €2.37. Based on the distribution chart, Q32 Bio ranks #999999 out of 1166 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Q32 Bio has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Q32 Bio's EPS without NRI compare to CAMP and CDXS?
According to the Biotechnology industry distribution chart, Q32 Bio ranks #999999 out of 1166 companies for EPS without NRI. This places Q32 Bio in the lower half of its industry. The industry median EPS without NRI is 16.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Biotechnology company?
The median EPS without NRI among Biotechnology companies is 16.65, based on 1,166 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Q32 Bio and its competitors. For the Biotechnology industry, the median EPS without NRI is 16.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Q32 Bio's current EPS without NRI is €2.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q32 Bio stock overvalued right now?
Q32 Bio (FRA:DB0) has a current EPS without NRI of €2.37. The current EPS without NRI is €2.37. Q32 Bio's overall GF Score™ is 17/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Q32 Bio (FRA:DB0), the current EPS without NRI is €2.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q32 Bio Business Description

Other Exchanges QTTB:USA
Address 830 Winter Street, Waltham, MA, USA, 02451
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
17GF Score

Get the complete analysis for FRA:DB0

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.33
Price